Jaceosidin
CAS: 18085-97-7
Ref. TM-T3824
1mg | 56,00 € | ||
5mg | 120,00 € | ||
10mg | 183,00 € | ||
25mg | 369,00 € | ||
50mg | 551,00 € | ||
100mg | 792,00 € | ||
1ml*10 (DMSO) | 87,00 € |
Información del producto
- 3′,6-Dimethoxy-4′,5,7-trihydroxyflavone
- 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-methoxy-
- 4′,5,7-Trihydroxy-3′,6-dimethoxyflavone
- 4′-Demethyleupatilin
- 5,7,4′-Trihydroxy-6,3′-dimethoxyflavone
- 5,7-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-methoxy-4H-1-benzopyran-4-one
- 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-methoxy-4H-chromen-4-one
- 6-Hydroxyluteolin 6,3′-dimethyl ether
- 6-Methoxyluteolin 3′-methyl ether
- Flavone, 4′,5,7-trihydroxy-3′,6-dimethoxy-
- Ver más sinónimos
- Jaseocidin
Jaceosidin has anti-oxidative activity. Jaceosidin has anti-inflammatory activity, also a microglial inhibitor with anti-neuroinflammation activity. aceosidin has anticancer activity, modulates the ERK/ATM/Chk1/2 pathway, leading to inactivation of the Cdc2-cyclin B1 complex, followed by G2/M cell cycle arrest in endometrial cancer cells. Jaceosidin has immunosuppressive effect through inhibiting T cell proliferation and activation, which is closely associated with its potent down-regulation of the IFN-γ/STAT1/T-bet signaling pathway. The pharmacokinetics of Jaceosidin may be dramatically affected by polymorphic CYP1A2, UGT1A1, and UGT1A7 responsible for the metabolism of Jaceosidin or by the coadministration of relevant CYP1A2 or UGT inhibitors or inducers.
Propiedades químicas
Consulta técnica sobre: TM-T3824 Jaceosidin
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.